Article Information
History
- August 5, 2022.
Article Versions
- Version 1 (July 12, 2022 - 08:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Hyunkyung Kim1,2,3,
- Kenneth E. Westerman2,4,
- Kirk Smith1,2,3,
- Joshua Chiou5,
- Joanne B. Cole2,3,6,7,
- Timothy Majarian2,
- Marcin von Grotthuss8,
- Josep M. Mercader1,2,3,6,
- Soo Heon Kwak9,
- Jaegil Kim2,10,
- Jose C. Florez1,2,3,6,
- Kyle Gaulton5,
- Alisa K. Manning2,4,6 and
- Miriam S. Udler1,2,3,6,*
- 1Diabetes Unit, Massachusetts General Hospital, Boston, MA 02114, USA
- 2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
- 3Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
- 4Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA 02114, USA
- 5Department of Pediatrics, University of California San Diego, San Diego, CA 92161, USA
- 6Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
- 7Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children’s Hospital, Boston, MA 02115, USA
- 8Takeda Pharmaceuticals, Cambridge, MA 02139, USA
- 9Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea
- 10GlaxoSmithKline, Cambridge, MA 02140, USA
- ↵* Corresponding author; email: mudler{at}mgh.harvard.edu
Posted August 05, 2022.
High-throughput Genetic Clustering of Type 2 Diabetes Loci Reveals Heterogeneous Mechanistic Pathways of Metabolic Disease
